Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. May 6, 2025; 13(13): 100700
Published online May 6, 2025. doi: 10.12998/wjcc.v13.i13.100700
Published online May 6, 2025. doi: 10.12998/wjcc.v13.i13.100700
Correction to: High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer
Shan Yang, Tian-Li Hui, Hao-Qi Wang, Xi Zhang, Yun-Zhe Mi, Meng Cheng, Wei Gao, Cui-Zhi Geng, Sai-Nan Li, Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China
Author contributions: All authors have written, read, and approved the correction.
Conflict-of-interest statement: All authors declare no relevant conflicts of interest associated with this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sai-Nan Li, MD, Department of Breast Center, The Fourth Hospital of Hebei Medical University, No. 169 Tianshan Street, Shijiazhuang 050011, Hebei Province, China. 48402144@hebmu.edu.cn
Received: August 23, 2024
Revised: October 12, 2024
Accepted: October 22, 2024
Published online: May 6, 2025
Processing time: 141 Days and 1.2 Hours
Revised: October 12, 2024
Accepted: October 22, 2024
Published online: May 6, 2025
Processing time: 141 Days and 1.2 Hours
Core Tip
Core Tip: This manuscript serves to correct the references in the article titled “High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer. World J Clin Cases 2023; 11(20): 4788-4799 PMID: 37583983 DOI: 10.12998/wjcc.v11.i20.4788”.